Paracetamol and metabolite pharmacokinetics in infants
Data concerning metabolism of paracetamol in infants are scant. Previous studies have examined urinary metabolite recovery rates after a single dose of paracetamol in either neonates (<6 weeks) or children (3–9 years). There are no studies investigating infants.
Infants (n=47) undergoing major craniofacial surgery were given paracetamol 19–45 mg/kg 6-, 8-, or 12-hourly as either elixir or suppository formulation for postoperative analgesia, after a loading dose of 33–59 mg/kg rectally during the operation. Serum was assayed for paracetamol concentration in 40 of these infants at 5, 8, 11, 14, 17 and 20 h postoperatively. Urine samples were collected every 3 h for 24 h in 15 of these infants. The clearances of paracetamol to glucuronide and sulphate metabolites as well as the urinary clearance of unmetabolised paracetamol were estimated using non-linear, mixed-effects models.
Mean (±SD) age and weight of the patients were 11.8±2.5 months and 9.1±1.9 kg. Clearances of paracetamol to paracetamol-glucuronide (%CV) and to paracetamol-sulphate were 6.6 (11.5) l/h and 7.5 (11.5) l/h respectively, standardised to a 70-kg person using allometric '1/4 power' models. Glucuronide formation clearance, but not sulphate formation, was related to age and increased with age from a predicted value in a neonate of 2.73 l/h/70 kg to a mature value of 6.6 l/h/70 kg with a maturation half-life of 8.09 months. Urine clearance of paracetamol-glucuronide, paracetamol-sulphate and unchanged paracetamol (%CV) were, respectively, 2.65, 3.03 and 0.55 (28) l/h/70 kg. The urine clearance of unchanged paracetamol and metabolites was related to urine volume flow rate. Clearance attributable to pathways other than these measured in urine was not identifiable. The glucuronide/sulphate formation clearance ratio was 0.69 at 12 months of age. Sulphate metabolism contributed 50% towards paracetamol clearance.
Glucuronide formation clearance increases with age in the infant age range but sulphate formation does not. Renal clearance of paracetamol and its metabolites increases with urine flow rate. This and other studies show that paracetamol metabolism to glucuronide appears to be similar in infants and children, but in adults is increased in comparison with children. Oxidative pathways were undetectable in this infant study and may explain, in part, the reduced incidence of hepatotoxicity in infants.
KeywordsParacetamol Metabolism Infants
- 2.Prescott LF (1996) Paracetamol (paracetamol). A critical bibliographic review. Taylor and Francis Publishers, LondonGoogle Scholar
- 7.McGrath PA, Brigham MC (1992) The assessment of pain in children and adolescents. In: Turk DC, Melzack R (eds) Handbook of pain assessment. The Guilford Press, New York, pp 295–314Google Scholar
- 8.Beal SL, Sheiner LB, Boeckmann A (1999) Nonmem user's guide. Division of Pharmacology, University of California, San FranciscoGoogle Scholar
- 11.Holford NHG (1996) A size standard for pharmacokinetics. Clin Pharmacokinet 30:329–332Google Scholar
- 12.Peters HP (1983) Physiological correlates of size. In: Beck E, Birks HJB, Conner EF (eds) The ecological implications of body size. Cambridge University Press, Cambridge, pp 48–53Google Scholar
- 14.Gabrielsson J, Weiner D (1994) Interspecies scaling. In: Gabrielsson J, Weiner D (eds) Pharmacokinetic and pharmacodynamic data analysis. Swedish Pharmaceutical Press Ltd, Stockholm, pp 153–171Google Scholar
- 21.Anderson BJ, McKee AD, Holford NH (1997) Size, myths and the clinical pharmacokinetics of analgesia in paediatric patients. Clin Pharmacokinet 33:313–327Google Scholar
- 25.West JR, Smith HW, Chasis H (1948) Glomerular filtration rate, effective renal blood flow, and maximal tubular excretory capacity in infancy. J Pediatr 32:10–18Google Scholar
- 30.Roberts I, Robinson MJ, Mughal MZ, Ratcliffe JG, Prescott LF (1984) Paracetamol metabolites in the neonate following maternal overdose. Br J Pharmacol 18:201–206Google Scholar
- 36.Hoffman DA, Wallace SM, Verbeeck RK (1990) Circadian rhythm of serum sulphate levels in man and paracetamol pharmacokinetics. Eur J Clin Pharmacol 39:143–148Google Scholar